celecoxib has been researched along with sc 236 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertenshaw, SR; Burton, EG; Carter, JS; Cogburn, JN; Collins, PW; Docter, S; Graneto, MJ; Gregory, SA; Isakson, PC; Koboldt, CM; Lee, LF; Malecha, JW; Miyashiro, JM; Penning, TD; Perkins, WE; Rogers, RS; Rogier, DJ; Seibert, K; Talley, JJ; Veenhuizen, AW; Yu, SS; Zhang, YY | 1 |
| Baurin, N; Chavatte, P; Lesieur, D; Marot, C; Yous, S | 1 |
| Jorgensen, WL; Wesolowski, SS | 1 |
| Chen, G; Chen, K; Huang, X; Jiang, H; Li, M; Liu, H; Luo, X; Shen, J; Xiong, B; Yang, Y | 1 |
| Hagmann, WK | 1 |
| Bakhle, YS; Chaves, CT; Ferreira-Alves, DL; Francischi, JN; Lima, AS; Moura, AC; Rocha, OA | 1 |
| Baratelli, F; Dubinett, SM; Holmes, EC; Mao, JT; Roth, MD; Serio, KJ; Strieter, RM; Zhu, L | 1 |
| Ang, KK; Hunter, N; Husain, A; Liao, Z; Mason, KA; Milas, L; Nakata, E; Raju, U | 1 |
| Corbett, JA; Ensor, NJ; Gibson, KA; Heitmeier, MR; Kelly, CB; Maziasz, TJ; Mullis, KG | 1 |
| Handa, H; Ito, T; Kawai, S; Kusunoki, N; Sakurai, N; Suguro, T | 1 |
| Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Pacheco, CM; Queiroz-Junior, CM | 1 |
| Chen, M; Gu, C; Liu, S; Wu, S; Yu, L; Zhong, D | 1 |
| Huwiler, A; Koch, A; Meyer Zu Heringdorf, D; Pfeilschifter, J; Völzke, A | 1 |
13 other study(ies) available for celecoxib and sc 236
| Article | Year |
|---|---|
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Molecular Structure; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides | 1997 |
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.
Topics: Benzene Derivatives; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Imidazoles; Isoenzymes; Isoxazoles; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrroles; Quantitative Structure-Activity Relationship; Spiro Compounds; Thiophenes | 2001 |
Estimation of binding affinities for celecoxib analogues with COX-2 via Monte Carlo-extended linear response.
Topics: Algorithms; Celecoxib; Combinatorial Chemistry Techniques; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrochemistry; Isoenzymes; Linear Models; Models, Chemical; Monte Carlo Method; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Structure-Activity Relationship; Sulfonamides | 2002 |
Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.
Topics: Algorithms; Binding Sites; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hydrogen Bonding; Isoenzymes; Models, Molecular; Molecular Conformation; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Quantitative Structure-Activity Relationship; Thermodynamics | 2002 |
The many roles for fluorine in medicinal chemistry.
Topics: Animals; Chemistry, Pharmaceutical; Enzyme Inhibitors; Fluorine; Fluorine Compounds; Humans; Protein Binding; Stereoisomerism | 2008 |
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Topics: Animals; Carrageenan; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Hindlimb; Hyperalgesia; Indomethacin; Inflammation; Isoenzymes; Lactones; Male; Pain Threshold; Piroxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Sulfonamides; Sulfones | 2002 |
Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Topics: Aged; Bronchoalveolar Lavage; Bronchoscopy; Calcimycin; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Celecoxib; Cyclooxygenase Inhibitors; Dinoprostone; Feasibility Studies; Female; Humans; Interleukin-10; Ionophores; Lipopolysaccharides; Lung Neoplasms; Macrophages, Alveolar; Male; Middle Aged; Pilot Projects; Pyrazoles; Smoking; Sulfonamides; Tumor Cells, Cultured | 2003 |
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
Topics: Animals; Celecoxib; Combined Modality Therapy; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Proteins; Neoplasms; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Sulfonamides | 2004 |
Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Glucose; Humans; Insulin; Insulin Secretion; Interferon-gamma; Interleukin-1; Islets of Langerhans; Isoenzymes; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2004 |
A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
Topics: Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Celecoxib; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; DNA Fragmentation; Enzyme Inhibitors; Fibroblasts; Genes, bcl-2; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones; Synovial Membrane | 2005 |
Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats.
Topics: Alveolar Bone Loss; Animals; Arachidonic Acid; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, Animal; Indomethacin; Male; Periodontal Attachment Loss; Periodontal Ligament; Periodontitis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2009 |
Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cation Transport Proteins; Celecoxib; Cell Line, Tumor; Cell Survival; Cisplatin; Copper Transporter 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA Adducts; Drug Interactions; Female; Gene Expression; Humans; Inhibitory Concentration 50; Intracellular Fluid; Mice; Mice, Inbred BALB C; Mice, Nude; Pyrazoles; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
Topics: Angiotensin II; Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1beta; Lysophospholipids; Male; MAP Kinase Signaling System; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Sulfonamides; Up-Regulation; Vasoconstrictor Agents | 2014 |